“Aims of the ASH guidelines and specific objectives: The purpose and primary goals of these guidelines are to provide evidence-based recommendations to facilitate management of acute and chronic pain in individuals living with SCD. To achieve these goals, the ASH guideline panel reviewed and critically appraised the published literature and made evidence-based recommendations. Through improved provider and patient education regarding the available evidence and evidence-based recommendations, these guidelines aim to provide support for shared decision making that will result in improved patient functioning and decreased pain-related morbidity for individuals living with SCD. The target audience includes patients and their caregivers, hematologists, general practitioners, internists, emergency medicine providers, and other clinicians and decision makers. Policymakers interested in these guidelines include those involved in developing local, national, or international plans with the goals of optimizing pain management for individuals living with SCD and decreasing patient suffering. This document may also serve as the basis for adaptation by local, regional, or national guideline panels. Questions prioritized by the ASH guideline panel on management of acute and chronic pain: Q1. In children and adults who seek treatment of acute pain, should a standardized protocol be used that includes (1) reduced time to first dose (,1 h from arrival) in addition to more frequent reassessment and dosing of pain medication (,30 min) and (2) tailored dosing (vs weight-based dosing)? Q2. Should nonopioid pharmacological therapies either in addition to or instead of opioids or other usual care interventions be used for the treatment of acute pain in children and adults with SCD? Q3. Should nonpharmacological therapies in addition to pharmacological therapies be used for the treatment of acute pain in children and adults with SCD? Q4. Should a hospital-based entity such as a day hospital or observation unit compared with regular ED care be used for children and adults with SCD who seek treatment of acute pain? Q5. Should a combination of continuous basal opioid infusion with on-demand dosing vs on-demand opioid dosing alone or scheduled intermittent opioid dosing be used for children and adults with SCD hospitalized for the treatment of acute pain? Q6. Should nonopioid pharmacological therapy, either in addition to or instead of opioids or other usual care interventions, be used for children and adults with SCD and chronic pain with another identifiable cause (eg, avascular necrosis, leg ulcers)? Q7. Should nonopioid pharmacological therapy, either in addition to or instead of opioids or other usual care interventions, be used for children and adults with SCD and chronic pain with no identifiable cause beyond SCD? Q8. Should nonpharmacological therapies be used in addition to pharmacological therapy for the treatment of chronic pain in children and adults with SCD? Q9. Should chronic opioid therapy vs no chronic opioid therapy or periodic opioid therapy be used in patients with SCD who have chronic pain? Q10. Should chronic monthly transfusion therapy to suppress hemoglobin S levels of ,30% vs no transfusions or on-demand transfusions be used for children and adults with SCD who have recurrent acute pain and/or chronic pain?”…. Rate how much you agree with the following statements (1-strongly disagree and 7-strongly agree) and provide specific details about each of your appraisal decisions: 1. A guideline’s objective (or objectives) is stated specifically; 2. The health question(s) covered by the guideline is stated specifically; 3. The population (patients, public, etc.) to which the guideline applies is explained precisely.
[Solved]: “Aims of the ASH guidelines and specific objectives:…
Need help with your Dosage Calculations & IV Flow case study or NCLEX preparation? Connect with a verified Nursing expert now.